TF and posterior cortical atrophy: The discovery of new biomarkers for PCa is currently a focal point.329 Recent findings suggest that the AS of the heterotrimeric transcription factor (TF) NF-Y could serve as a biomarker for further refinement of molecular subtypes among PCa patients.